Sigma Healthcare Limited (FRA:S5YA)
Germany · Delayed Price · Currency is EUR | Market Cap | 19.76B +7.4% |
| Revenue (ttm) | 5.42B +208.9% |
| Net Income | 340.75M +97.1% |
| EPS | 0.03 -72.9% |
| Shares Out | n/a |
| PE Ratio | 57.99 |
| Forward PE | 39.94 |
| Dividend | 0.02 (1.15%) |
| Ex-Dividend Date | Mar 4, 2026 |
| Volume | n/a |
| Average Volume | n/a |
| Open | 1.670 |
| Previous Close | 1.680 |
| Day's Range | 1.670 - 1.670 |
| 52-Week Range | 1.500 - 1.830 |
| Beta | n/a |
| RSI | 59.41 |
| Earnings Date | May 15, 2026 |
About Sigma Healthcare
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia. It offers support services to a network of franchised retail pharmacies; third and fourth party logistics services to pharmaceutical manufacturers and other supplier partners; and health services. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores brand names. It also offers products through online. The company was founded in 1912 and is headquartered... [Read more]
Financial Performance
In fiscal year 2025, Sigma Healthcare's revenue was 6.00 billion, an increase of 82.18% compared to the previous year's 3.29 billion. Earnings were 529.91 million, a decrease of -2.05%.
Financial numbers in AUD Financial StatementsNews
Sigma Healthcare posts record jump on $5.8 bln merger with Chemist Warehouse
Shares in Australia's Sigma Healthcare surged more than 76% in early trade on Wednesday to post a record intraday jump, after the company said on Monday it would merge with Chemist Warehouse Group to ...